Comparison of stage III mucinous and serous ovarian cancer: a case-control study

• Päätekijät: Zeliha Firat Cuylan (Tekijä), Emine Karabuk (Tekijä), Murat OZ (Tekijä), Ahmet Taner Turan (Tekijä), Mehmet M. Meydanli (Tekijä), Salih Taskin (Tekijä), Mustafa Erkan Sari (Tekijä), Hanifi Sahin (Tekijä), Suat C. Ulukent (Tekijä), Ozgur Akbayir (Tekijä), Kemal Gungorduk (Tekijä), Tayfun Gungor (Tekijä), Mehmet F. Kose (Tekijä), Ali Ayhan (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2018-10-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background The purpose of this case-control study was to compare the prognoses of women with stage III mucinous ovarian carcinoma (MOC) who received maximal or optimal cytoreduction followed by paclitaxel plus carboplatin chemotherapy to those of women with stage III serous epithelial ovari...